Resvi 006 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GSK's Arexvy vaccine for RSV can remain effective against a range of variants and produces strong antibody responses against distinct viral strains.

Anna frankLionel sacconnayScience translational medicineAdult respiratory syncytial virusRespiratory syncytial virusScience translational medicineSvpref3 as01Resvi 006